Neural activation by digitalis has been shown to facilitate the development of cardiac arrhythmias and to mediate digitalis-induced increases in systemic and coronary resistance. Recent studies in our laboratory have implicated an area in the medulla within 2 inn of the obex as the locus for the neurally mediated arrhythmogenic properties of digitalis. To localize the site of digitalis-induced neural activation leading to increased coronary vascular resistance, 56 cats were anesthetized and an electromagnetic flow probe placed around the proximal right coronary artery. We used measurements of mean coronary flow and mean central aortic pressure and determined mean coronary vascular resistance every 6 minutes. Coronary vascular resistance remained constant in control cats not receiving digitalis. Ouabain, 20 fig/kg, given intravenously, significantly increased coronary resistance for 40 minutes. Complete transaction of the neuraxls at the medullary level 2 mm above the obex failed to alter the rise in coronary resistance caused by ouabain. However, brainstem transection 2 mm below the obex completely abolished the rise in resistance caused by ouabain. a-Adrenergic blockade with phenoxybenzamine (0.5 mg/kg) In above-obex sectioned cats also abolished the ouabain-induced rise in coronary resistance. The administration of a highly polar cardiac glyoside, ASI-222, also produced a significant rise in coronary vascular resistance lasting 45 minutes, despite the fact that CSF samples obtained from the cisterna magna did not contain detectable levels of ASI-222. These studies indicate that an area of the medulla within 2 mm of the obex is involved in the mediation of the coronary vasoconstrictor properties of digitalis. These studies further implicate an area devoid of an effective blood brain barrier, and are consistent with the involvement of the area postrema in these vasoconstrictor effects. Ore Res 49: [226][227][228][229][230][231][232][233] 1981 DIGITALIS is well known to have a vasoconstrictor effect on the systemic arterial, venous, and splanchnic circulations (Ross et aL, 1960; Mason et al., 1964; Harrison et al., 1969; Katz et al., 1978) . The rise in coronary vascular resistance in response to rapidly administered cardiac glycosides has been demonstrated to be mediated, in part, by the central nervous system (Vatner et al., 1971; Garan et al., 1974) . Vatner et al. (1971) demonstrated that ouabain caused a rise in coronary vascular resistance in dogs when injected intravenously at a dose of 20 /ig/kg. This study and that of Hamlin et al. (1974) demonstrated a neurogenic component in the coronary vasoconstrictor effects of digitalis that could be abolished by a-adrenergic receptor blockade using phenoxybenzamine. Cross-perfusion experiments, in which the isolated head of an operative dog was perfused with digoxin-containing blood from a donor dog, thus keeping digoxin levels in the remainder of the operative dog very low, showed a degree of coronary vasoconstriction in the operative From the Cardiovascular Division,
dog similar to that observed with systemic digoxin administration. These experiments by Garan and colleagues (1974) provided convincing evidence that the a-mediated rise in coronary vascular resistance caused by digitalis is mediated through the CNS. However, the specific CNS pathways or structures by which this mediation arises have not been defined. Recent studies in our laboratory have localized an area of the brainstem within 2 mm of the obex that appears to be a key center for the cardiac arrhythmogenic effects of digitalis (Somberg and Smith, 1979) . These studies, combined with observations on highly polar cardiac glycoside derivatives that fail to cross the normal blood brain barrier but cause neural facilitation of cardiac arrhythmias, suggest the area postrema, a region devoid of an effective blood brain barrier, as the locus of the neurally mediated arrhythmogenic properties of digitalis (Somberg et al., 1980) . Based on these previous findings, we have performed experiments to localize the neurally mediated coronary vasoconstrictor effect of digitalis using the cat model previously studied in our laboratory (Somberg et al., 1978 (Somberg et al., , 1980 .
Methods

General Procedures
Experiments were performed on 65 cats of either sex weighing between 2.2 and 4.1 kg. Animals were anesthetized with sodium pentobarbital (Nembutal), 30 mg/kg, injected intravenously. Tracheal cannulation was performed and animals were ventilated with room air by means of a respirator. Respiratory rate and total volume were adjusted to maintain arterial blood pH, P02, and PCO2 within normal limits for the cat (Fink and Schoolman, 1963) . Body temperature was measured by means of a rectal thermometer and maintained at 37°C with radiant heat. A brachial artery was cannulated for the continuous recording of peripheral blood pressure and to obtain arterial blood samples. A femoral vein was cannulated for the administration of drugs. A standard lead II electrocardiogram was recorded continuously. The right femoral artery was cannulated and a catheter advanced to a central aortic position to measure central aortic pressure. Animals then were placed on their left side and a right lateral sternotomy performed, a pericardial cradle formed, and a short segment of the right coronary artery exposed. Care was taken not to damage fine nerves running along the coronary vessels. An electromagnetic flow probe {Carolina Medical Electronics, 400 series) was placed around the vessel. Zero flow and calibration were performed electronically using the Carolina Medical Electronics System (series 501 square wave flowmeter). Both pulsatile and mean coronary flow, together with pulsatile and mean central aortic pressure, were recorded simultaneously with the electrocardiogram on a Hewlett-Packard recorder.
In four experiments, the right coronary artery was cannulated at the end of the experiment and the mean coronary pressure was found to be superimposable on the mean aortic pressure recorded from the central aortic catheter. Angiotensin infusion caused a parallel and identical rise in mean aortic and coronary pressure measured in this way.
Neurosurgical Techniques
To prevent the known vagomimetic effects of digitalis and the resulting changes in heart rate from obscuring other hemodynamic changes, all animals underwent cervical vagotomy with care not to disturb other nerves running in that region. In some cats, neuraxis transection was performed as previously described (Somberg and Smith, 1979) . The cats were placed in a head clamp with the neck flexed. The dorsal muscles inserting in the base of the skull were removed by blunt technique, the spinal cord exposed, and a small portion of the posterior inferior skull removed using ronjeurs. The dorsum of the brainstem was then exposed and transection was performed 2 mm above or below the level of the obex.
Blood Pressure Support Technique
Neuraxis transection either below or above the obex is associated with a fall in mean arterial pressure. To control this variable, in three experiments a reservoir system was used. After neuraxis transec-tion below the level of the obex, volume expansion with normal saline, human serum albumin, and plasma (universal donor), as well as compatible feline whole blood from a donor animal, were used to maintain a mean arterial pressure of 90 ± 5 mm Hg. The hematocrit was maintained above 35%, using a reservoir of feline donor blood connected to the left femoral vein. When pressure and hematocrit fell, the reservoir was raised to administer whole blood to the animal. When stable hemodynamic conditions had been achieved, ouabain was infused. Out of 12 cats studied in this fashion, the technique was successful in only three. In the remaining nine cats, despite vigorous efforts, blood pressure could not be maintained at 90 mm Hg or higher.
ASI-222 Administration and Assay
ASI-222 [3-/ 8-0-(4-amino-4,6-dideoxy-y3-D-galactopyranosyl)-digitoxigenin; Ash-Stevens Institute], a highly polar amino sugar cardiac glycoside derivative, was given intravenously to six cats at a dose of 20 /og/kg. Previous studies have shown that this agent does not enter the cerebrospinal fluid in detectable amounts in the cat (Somberg et al., 1980) or in the dog (Mudge et al., 1978) . Five and 60 minutes after infusion of ASI-222, CSF samples were taken through a cannula inserted at the level of C-l with the head flexed. In no case was blood noted in the CSF samples. Samples were then assayed for ASI-222 by means of previously described radioimmunoassay capable of detecting concentrations as low as 0.1 ng/ml (Mudge et al., 1978) .
Experimental Protocols
Ouabain Studies
All animals were prepared and instrumented as described. After surgery had been completed, a period of 1 hour elapsed before the study was begun. All animals were observed for 1 hour after drug administration. Ouabain (20 jigAg) was administered in 1 ml of saline over 1 minute to six animals, whereas six control animals received vehicle alone. The dose of ouabain was chosen on the basis of previous work by Vatner and associates (1971) demonstrating ouabain-induced coronary vasoconstriction in the dog mediated chiefly by an a-adrenergic mechanism without signs of cardiac arrhythmias. Three animals underwent below-obex neuraxis transection and three above-obex txansection. Neither group of animals received ouabain. Since coronary resistance in the two groups was essentially identical, they were combined for purpose of comparison. Six animals underwent above-obex transection and received ouabain (20 ^g/kg). An additional six cats underwent below-obex transection and received ouabain (20 /ig/kg)a-Blockade Studies a-Adrenergic blockade was established with phenoxybenzamine (0.5 mg/kg). Six animals re- VOL. 49, No. 1, JULY 1981 ceived phenoxybenazmine 30 minutes after surgery. Thirty minutes later, ouabain (20 fig/kg) was administered. The adequacy of a-blockade was tested with intravenous doses of norepinephrine (0.01 to 0.07 mg). These doses of norepinephrine in non-ablocked animals [control animals (n -6) as listed in previous paragraph] caused a marked pressor response. The lack of a pressor response was used as proof of adequate a-blockade. Six additional cats underwent above-obex neuraxis transection followed by a blockade and then ouabain administration.
Blood Pressure Support Studies
Three additional animals that underwent belowobex section had their blood pressure maintained successfully at or above 90 mm Hg. A blood reservoir system was used to maintain mean pressure from falling below 90 mm Hg following neuraxis transection. Once blood pressure support had been successful and 1 hour had elapsed after neuraxis transection, ouabain (20 fig/kg) was infused.
Polar Cardiac Glycoside Administration Experiments
ASI-222 was administered intravenously at a dose of 20 /ig/kg in 1 ml of saline over 1 minute to 11 animals, of which three had undergone belowobex section and two above-obex section. Five and 60 minutes after the infusion, CSF samples were obtained from the six cats not undergoing brainstem transection and CSF glycoside levels were measured.
Data Analysis
All determinations of hemodynamic measurements were made using the mean of five representative beats. Coronary vascular resistance was determined as the quotient of mean central aortic pressure divided by right coronary artery flow, and the percentage change in resistance from baseline was determined. Baseline was defined as the period immediately preceding drug administration after all surgery had been performed and 1 hour had elapsed. The mean is reported ± the standard error of the mean. Statistical significance was determined by the analysis of variance. P values are reported for the overall group comparisons and, where appropriate, the individual comparisons as well.
Results
Ouabain Studies
As summarized in Figure 1 , ouabain injected intravenously in six neurally intact animals caused a significant rise in coronary resistance persisting for 40 minutes, compared to six animals receiving vehicle only (P < 0.01). This rise in coronary resistance was characterized by an increase in pressure and a fall in coronary flow. The pattern of change in coronary resistance over time consistently showed an initial marked increase in the first 5 minutes that was partially attenuated at 10 minutes; the response plateaued over the next 30 minutes, followed by a slow decline toward baseline coronary resistance. In six animals that did not receive ouabain, coronary resistance remained unchanged over one hour (Fig. 1) .
Complete neuraxis transection 2 mm above the obex in six cats failed to abolish, and in fact accentuated, the early rise in coronary resistance caused by ouabain (Fig. 2) . Although the initial rise in resistance in the above-obex sectioned group was more marked at 1 and 5 minute in the group receiving ouabain alone, the prolonged increase in resistance with slow fall toward control values paralleled that of the neurally intact group receiving ouabain (Fig. 2) .
To test the hypothesis that the coronary vasoconstrictor effects of ouabain are mediated at a brainstem level similar to that previously shown to mediate the neural component of the arrhythmogenic effects, another group of cats underwent below-obex section. In marked contrast to neurally intact and above-obex sectioned animals, brainstem transection 2 mm below the level of the obex in six cats completely abolished the ouabain-induced rise in coronary resistance (Fig. 2) . Coronary resistance in below-obex transected animals receiving ouabain (O) . A second group of six cats also received ouabain (20 ng/kg), as well as having neuraxis transection 2 mm above the level of the obex. Six additional cats underwent beloiv-obex neuraxis transection and received ouabain (A) and another group underwent neuraxis transection above (n -3) or below (n = 3) the level of the obex but did not receive ouabain (Q). Complete neuraxis transection above the obex accentuated the ouabain-induced increase in coronary resistance significantly at 1 and 6 minutes. Transection below the level of the obex abolished the ouabaininduced increase in coronary resistance. Asterisks denote the significantly greater rise in resistance of the group receiving ouabain compared to the group not receiving drug and not undergoing neuraxis transection. The group receiving ouabain (O) was noted in Figure 1 .
was not significantly different over 1 hour of study from animals with neuraxis transection either below or above the level of the obex not receiving ouabain.
The data for the latter two groups were pooled in Figure 3 , since results from the two groups were identical.
a-Blockade Studies
The role of the a-adrenergic nervous system in the ouabain-induced rise in coronary resistance was studied in neurally intact {n = 6) and in above-obex sectioned cats (n -6) pretreated with the a-adrenergic blocking agent phenoxybenzamine. After testing for adequacy of a-blockade with intravenous norepinephrine infusions (see Methods), ouabain administration (20 fig/kg) to neurally intact animals produced a small increase in coronary vascular re-
The effect of phenoxybenzamine on coronary vascular resistance changes induced by ouabain. Aboveobex sectioned cats (n -6) were pretreated with the aadrenergic blocking agent phenoxybenzamine (OJ. After adequacy of a-bhckade had been evaluated, ouabain (20 fig/kg ) produced a small increase in coronary vascular resistance at 5 minutes but, thereafter, coronary resistance was unchanged and significantly different from the above-obex sectioned group receiving only ouabain (n = 6) (%). a-Blockade also abolished the increase in coronary resistance in a neurally intact group of six cats (O) . Asterisks denote the significant increase in resistance in the above-obex sectioned group compared to the a-blocked group. The groups are significantly different (P < 0.01). sistance at 5 minutes but, thereafter, coronary resistance was essentially unchanged (Fig. 3) . The significant rise in coronary resistance seen in the above-obex sectioned group in response to ouabain was also prevented by a-blockade ( Fig. 3 ).
Blood Pressure Support Studies
Transection of the neruaxis either above or below the level of the obex significantly reduced systemic arterial blood pressure. The mean heart rates and arterial blood pressures recorded 1 hour after surgery but prior to drug administration are summarized in Table 1 . Neurally intact animals had a mean heart rate similar to that of neuraxis-transected animals, but mean systemic pressure was significantly (and similarly) lower in above-and below-obex transected animals and in a-blocked animals. Heart rate was significantly lower in the a-blocked group. Animals with below-obex transection with mean arterial pressure maintained at a VOL. 49, No. 1, JULY 1981 level of 90 mm Hg or above with a reservoir system did not demonstrate an increase in coronary resistance when ouabain was administered (Fig. 4) . In fact, this group's response to ouabain administration was quite similar to that of the group that received ouabain after neuraxis transection below the obex but did not have blood pressure support (Fig. 2) . Thus, the rise in coronary resistance produced by ouabain is abolished by below-obex transecton, and this response is unchanged when the blood pressure fall caused by neurosurgical procedures is not permitted to occur.
Polar Cardiac Glycoside Administration Experiments.
When the highly polar cardiac glycoside derivative ASI-222 was administered intravenously to neurally intact cats in a dose of 20 ftg/kg, coronary The effect of blood pressure support on changes in coronary resistance in below-obex sectioned cats. Three animals undergoing below-obex neuraxis transection had mean blood pressure maintained at or above 90 mm Hg (9) and received ouabain. Coronary resistance did not change and was not different from a group (n = 6) undergoing neuraxis transection but not receiving ouabain (O) . The response of neurally intact animals (n = 6) to ouabain administration is shown again for comparison fO) and is significantly different (*) from the group not receiving ouabain.
vascular resistance increased significantly (Fig. 5 ). ASI-222 caused an initial rise over the first 10 minutes, followed by partial attenuation of the response at 15 minutes. A prolonged rise in resistance occurred over the next 30 minutes compared to animals not receiving drugs. This biphasic effects was more pronounced than with the conventional glycoside ouabain (Fig. 5) . Cerebrospinal fluid levels of ASI-222 were measured at 5 and 60 minutes after drug administration. No detectable level of ASI-222 was found in these samples at the time of peak effect on coronary resistance or 1 hour after drug administration. Neuraxis transection either above or below the level of the obex was performed in animals receiving 20 /ig/kg of ASI-222. Transection below the level of the obex (n = 3) abolished the coronary vasoconstrictor response while transection above the level of the obex (n = 2) did not change the coronary vasoconstriction produced by ASI-222.
Discussion
It is well known that the digitalis glycosides affect the tone of both the arterial and venous vasculature. These effects are complex and, depending on the dose and model system employed, may involve both direct and neurally mediated components (Ross et al., 1960; Stark et al., 1972) . Work from several laboratories has demonstrated a direct effect of digitalis to increase vascular resistance. Excised arterial and venous strips contact when exposed to digitalis glycosides (Cow, 1911; Franklin, 1925; Leonard, 1957; Lendle and Mercker, 1961) . Cardiac The effect of a highly polar cardiac glycoside derivative on coronary resistance. was given to six cats resulting in increased coronary vascular resistance (9) . The biphasic response to ASI-222 tended to be more marked than to ouabain, also plotted for comparison (O), but the two groups are not significantly different.
glycosides cause a rise in splanchnic vascular resistance in the dog (Katz et al., 1978; Harrison et al., 1969) . Stark and associates (1972) demonstrated a rise in canine skeletal muscle vascular resistance in response to acetylstrophanthidin comprising both direct and neurally mediated components. A number of other studies in both dogs and humans have shown increases in systemic vascular resistance following digitalis administration (Dock and Tainter, 1930; Williams et al., 1958; Mason et al., 1964) . Recent evidence suggests that inhibition of the sodium pump of vascular smooth muscle cells by cardiac glycosides may increase intracellular concentrations of free calcium ion, leading in turn to an increase in tone (Lang and Blaustein, 1980) . In intact animals, an important role of the autonomic nervous system in mediating the cardiac glycoside-induced rise in systemic and coronary vascular resistance has been demonstrated (Vatner et al., 1971; Stark et al., 1972; Garan et al., 1974; Hamlin et al., 1974) . In the experiments described in the present study, we chose an experimental model and a dose of ouabain designed to emphasize the neurally mediated effects. Our findings demonstrate that intravenous administration of ouabain to the cat under the conditions employed elicits an a-adrenergically mediated coronary vasoconstrictor response involving medullary structures and/or pathways at the level of the obex.
The rise in coronary resistance was characterized by an initial rapid increase, usually followed by a transient drop toward baseline, followed by a prolonged effect declining to baseline by the end of 1 hour. a-Adrenergic blockade with phenoxybenzamine markedly reduced the initial rise in resistance and completely abolished the prolonged component. Below-obex transection of the neuraxis totally abolished both early and later increases in resistance caused by ouabain. Neuraxis transection 2 mm above the level of the obex appeared to potentiate the initial rise, implying an influence of more rostral centers on coronary resistance. Our findings are consistent with the possibility that higher centers provide a tonic dilatory effect, and that their ablation leads to a more pronounced a-mediated vasoconstrictor response to digitalis.
Neuraxis transection was noted in our studies to cause a significant lowering in mean arterial pressure. This reduction could possibly influence the measurement of coronary resistance and the response to intravenously administered ouabain. However, similar degrees of pressure reduction from below-and above-obex transection affected the response to ouabain in markedly different ways. Moreover, when a reservoir technique was used to maintain pressure in below-obex transected animals, these animals failed to show a rise in resistance in response to ouabain administration. Thus, although neuraxis transection-induced reduction in blood pressure could modify the measurement of coronary resistance, it did not prevent the demon-stration that a region within 2 mm of the obex plays a central role in the changes in coronary resistance due to the administration of ouabain.
ASI-222, a highly polar glycoside that did not enter the cerebrospinal fluid, elicited the same coronary vasoconstrictor effects as ouabain (Fig. 6) . This finding suggested a region devoid of an effective blood brain barrier as the focus of the neurally mediated coronary vasoconstrictor effects of digitalis. Such a region could be the area postrema, previously implicated as a site involved in the neurally mediated arrhythmogenic effects of digitalis (Somberg and Smith, 1979; Somberg et al, 1980) . The area postrema comprises a portion of the sides and floor of the fourth cerebral ventricle, forming the dorsal landmark known as the obex (Taber, 1961) . This highly vascular area lacks normal blood brain barrier properties and has been shown by B orison and Wang (1953) to mediate the emetic effects of digitalis. Since the work of Dittmar (1873) and Ranson and Billingsley (1916) , a number of reports have suggested circulatory control centers lying at the floor of the fourth cerebral ventricle in an area now known to include the area postrema. Recently, Barnes and associates (1979) have reported that electrical stimulation of the area postrema caused a rise in systemic vascular resistance. This rise in systemic resistance due to area postrema stimulation may be related to the rise in peripheral vascular resistance caused by digitalis. This possibility is supported by the report of Bircher and associates (1963) that small amounts of deslanoside administered into the fourth cerebral ventricle elicited marked pressor effects (50-80% above control), whereas administration of equal amounts of deslanoside to the lateral or third ventricles elicited delayed and reduced responses.
Other evidence implicating brainstem structures, possibly including the area postrema, in digitalisinduced toxicity comes from studies indicating that putative central neurotransmittera are most effective in precipitating digitalis toxicity when administered via the fourth cerebral ventricle . Also, the digitalis glycoside deslanoside caused significant alteration in CNS 3 H-serotonin uptake only in the area postrema . Centrally administered 3 H-ouabain was found to be more highly concentrated in the area postrema than in other midbrain and brainstem structures (Schoener et al., 1976) .
Activation of the area postrema may affect sympathetic autonomic outflow via interconnections with other brainstem loci with autonomic effector actions (Morest, 1967; Klara and Brizzee, 1977) . The area postrema has been reported to connect directly with descending autonomic pathways (Claresu and Thomas, 1975) . Thus, the area postrema or surrounding structures seem to mediate the neural component of the digitalis-induced rise in coronary vascular resistance.
Although coronary blood flow has been thought to be regulated primarily by the metabolic demands of the heart, recent studies suggest that autoregulation at the myocardial level can be overridden, at least partially, by adrenergic vasoconstriction. Mohrman and Feigl (1978) demonstrated that aadxenergically mediated coronary vasoconstriction competes with metabolic vasodilation, the net effect being to limit the metabolically induced increase in coronary flow. a-Adrenergic activation can attenuate the coronary vasodilator response to severe exercise (Murray and Vatner, 1979) and reactive hyperemia (Schwartz and Stone, 1976) . Cutaneous exposure to cold can limit coronary vasodilation elicited by atrial pacing in patients with coronary artery disease (Mudge et al., 1979) . Thus, it is possible that the coronary vasoconstrictor response to rapid intravenous administration of digitalis may override the local metabolic dilating effects and compromise myocardial blood supply. Studies in humans have produced conflicting results. Loeb et al. (1979) reported no effect of rapid intravenous infusion of ouabain (15 /ig/kg) on resting coronary sinus flow and no change in the response to atrial pacing. Ferlinz and colleagues (1979) reported that ouabain (7 fig/kg ) increased coronary sinus blood flow and did not affect the response to atrial pacing. However, coronary vascular resistance increased after rapid (but not slow) infusion of ouabain, 15 /igAg (DeMots et al., 1978) , and resting coronary blood flow decreased and resistance increased after a 5-minute infusion of 1 mg of digoxin (Kotter et al., 1978) .
Although among these studies there are considerable methodological differences, it seems reasonable to suspect that cardiac glycoside-induced modulation of neural influences plays a significant role in the regulation of coronary flow in man. In any case, the experimental findings reported here indicate that, in the cat, the neurally mediated vasoconstrictor effects of ouabain are mediated by structures and/or pathways within or in close proximity to the area postrema.
Excitation, Conduction, and Reflection of Impulses in Isolated Bovine and Canine
Cardiac Purkinje Fibers JOSE JALIFE AND GORDON K. MOE SUMMARY When an impulse arrives at an area of impaired conductivity, a slowly rising electrotonic potential may bring the distal tissue to threshold after a delay imposed by the passive electrical properties of the system and by the time-dependent changes of these properties during diastole. This phenomenon can be demonstrated in Purkinje strands in which an area of depressed conductivity has been induced by the impedance of a sucrose gap and can be mimicked by the application of relatively long current pulses of low amplitude. The functional refractory period, defined as the shortest interval between two distal responses both propagated across the gap, was determined by the application of premature stimuli at progressively earlier Intervals. The time course of the recovery of excitability as well as the conduction intervale could be varied almost at will by manipulating the electrical impedance between proximal and distal ends of the fiber. When the time of activation of the distal end across the gap exceeded the absolute refractory period of the proximal segment, the impulse reflected back as a closely coupled premature beat. Time-dependent changes in the passive electrical properties of the depressed segment may set the conditions for reflection. The results suggest the possibility of reflection as a mechanism for premature beats and demonstrate obligatory shifts in the patterns of premature reentrant activity accompanying changes in basic cycle length. These experiments provide important clues for the distinction between reentrant and parasystolic mechanisms. Circ Res 49: [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] 1981 IN previous publications we have proposed the Purkinje fiber-sucrose gap preparation as a model for ventricular parasystole (Jalife and Moe, 1976; Moe et aL, 1977; Jalife and Moe, 1979) . In those studies, the dynamic behavior of a spontaneous pacemaker in response to electrotonic depolarizations across an area of impaired conductivity was described by a biphasic phase response curve
